These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 1601137

  • 1. Was the Dalkon Shield a safe and effective intrauterine device? The conflict between case-control and clinical trial study findings.
    Mumford SD, Kessel E.
    Fertil Steril; 1992 Jun; 57(6):1151-76. PubMed ID: 1601137
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pelvic inflammatory disease with intrauterine device use: a reassessment.
    Kessel E.
    Fertil Steril; 1989 Jan; 51(1):1-11. PubMed ID: 2642807
    [Abstract] [Full Text] [Related]

  • 4. Medical records in litigation: the Dalkon Shield story.
    Byrne K.
    AMRO; 1992 Feb; 32(5):11-4. PubMed ID: 10117045
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An association between the Dalkon Shield and complicated pregnancies among women hospitalized for intrauterine contraceptive device--related disorders.
    Kahn HS, Tyler CW.
    Am J Obstet Gynecol; 1976 May 01; 125(1):83-6. PubMed ID: 1275008
    [Abstract] [Full Text] [Related]

  • 8. The Dalkon Shield debate.
    Goodhue PA.
    Conn Med; 1983 Mar 01; 47(3):138-41. PubMed ID: 6851548
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intrauterine devices and pelvic inflammatory disease: evolving perspectives on the data.
    Burkman RT.
    Obstet Gynecol Surv; 1996 Dec 01; 51(12 Suppl):S35-41. PubMed ID: 8972501
    [Abstract] [Full Text] [Related]

  • 13. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
    Tatum HJ, Beltran RS, Ramos R, Van Kets H, Sivin I, Schmidt FH.
    Am J Obstet Gynecol; 1996 Nov 01; 175(5):1231-5. PubMed ID: 8942493
    [Abstract] [Full Text] [Related]

  • 14. Complications of use of intrauterine devices among HIV-1-infected women.
    Sinei SK, Morrison CS, Sekadde-Kigondu C, Allen M, Kokonya D.
    Lancet; 1998 Apr 25; 351(9111):1238-41. PubMed ID: 9643743
    [Abstract] [Full Text] [Related]

  • 15. Intrauterine contraceptive device and pelvic inflammatory disease.
    Toivonen J.
    Ann Med; 1993 Apr 25; 25(2):171-3. PubMed ID: 8489756
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. IUDs, inflammation, and infection: assessment after two decades of IUD use.
    Schmidt WA.
    Hum Pathol; 1982 Oct 25; 13(10):878-81. PubMed ID: 6751984
    [Abstract] [Full Text] [Related]

  • 18. Intrauterine devices and pelvic inflammatory disease: recent developments.
    Grimes DA.
    Contraception; 1987 Jul 25; 36(1):97-109. PubMed ID: 3311628
    [Abstract] [Full Text] [Related]

  • 19. A bright future for IUDS: new technology and research trigger expanded interest.
    Netw Res Triangle Park N C; 1991 Sep 25; 12(2):1, 4-5. PubMed ID: 12284272
    [Abstract] [Full Text] [Related]

  • 20. Current assessment of the use of intrauterine devices.
    Westhoff CL.
    J Nurse Midwifery; 1996 Sep 25; 41(3):218-23. PubMed ID: 8708805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.